| From that article in my last post.>>>>>>>>Solomon—with cocounsel at Weitz and Luxembourg in New Jersey—has filed 21 suits in state court in Middlesex, New Jersey, dealing with Remicade and Enbrel. The cases involve myriad medical problems associated with the drugs, including TB, sepsis, MS, lupus, and death. The defendants are the manufacturers and marketers of the drugs—for Remicade, Centocor Inc., Johnson & Johnson, and Ortho-McNeil Pharmaceutical, Inc.; for Enbrel, Amgen Inc., Immunex Corp., Immunex Manufacturing, Wyeth, and Wyeth Pharmaceuticals, Inc. (See, e.g., Mire v. Amgen, Inc., No. L-4063-03 (N.J., Middlesex County Super. Ct. filed May 30, 2003); Funk v. Centocor, Inc., No. MID-L-7645-03 (N.J., Middlesex County Super. Ct. filed Oct. 22, 2003).)<<<<<<<<<<<<< |
